PANCRELIPASE PROTEASE
Substance profile for UNII 3560D81V50, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Substance Identity#
- UNII
- 3560D81V50
- Preferred term
- PANCRELIPASE PROTEASE
- Registry number
- 9001-94-9
- Ingredient type
- INGREDIENT SUBSTANCE
Chemical And Database Identifiers#
- RxCUI
- 1427034
- PubChem
- 0
- NCIt
- C84041
- INN ID
- 0
- ITIS
- 180722
- NCBI
- 9823
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| PANCRELIPASE PROTEASE | ACTIVE INGREDIENT | 3560D81V50 | These highlights do not include all the information needed to use ZENPEP safely and effectively. See full prescribing information for ZENPEP. ZENPEP ® (pancrelipase) delayed release capsules Initial U.S. Approval: 2009 | 1 | |
| PANCRELIPASE PROTEASE | ACTIVE MOIETY | 3560D81V50 | These highlights do not include all the information needed to use ZENPEP safely and effectively. See full prescribing information for ZENPEP. ZENPEP ® (pancrelipase) delayed release capsules Initial U.S. Approval: 2009 | 1 | |
| PANCRELIPASE PROTEASE | ACTIVE MOIETY | 3560D81V50 | Drug Facts | 1 | |
| PANCRELIPASE PROTEASE | ACTIVE INGREDIENT | 3560D81V50 | These highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON. CREON (pancrelipase) delayed-release capsules for oral use Initial U.S. Approval: 2009 | 5 | |
| PANCRELIPASE PROTEASE | ACTIVE MOIETY | 3560D81V50 | These highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON. CREON (pancrelipase) delayed-release capsules for oral use Initial U.S. Approval: 2009 | 5 | |
| PANCRELIPASE PROTEASE | ACTIVE MOIETY | 3560D81V50 | These highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON. CREON (pancrelipase) delayed-release capsules for oral use Initial U.S. Approval: 2009 | 2 | |
| PANCRELIPASE PROTEASE | ACTIVE INGREDIENT | 3560D81V50 | These highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON. CREON (pancrelipase) delayed-release capsules for oral use Initial U.S. Approval: 2009 | 2 | |
| PANCRELIPASE PROTEASE | ACTIVE INGREDIENT | 3560D81V50 | These highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON. CREON (pancrelipase) delayed-release capsules for oral use Initial U.S. Approval: 2009 | 2 | |
| PANCRELIPASE PROTEASE | ACTIVE MOIETY | 3560D81V50 | These highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON. CREON (pancrelipase) delayed-release capsules for oral use Initial U.S. Approval: 2009 | 2 | |
| PANCRELIPASE PROTEASE | ACTIVE INGREDIENT | 3560D81V50 | These highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON. CREON (pancrelipase) delayed-release capsules for oral use Initial U.S. Approval: 2009 | 2 | |
| PANCRELIPASE PROTEASE | ACTIVE MOIETY | 3560D81V50 | These highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON. CREON (pancrelipase) delayed-release capsules for oral use Initial U.S. Approval: 2009 | 2 | |
| PANCRELIPASE PROTEASE | ACTIVE INGREDIENT | 3560D81V50 | CREON (PANCRELIPASE) CAPSULE, DELAYED RELEASE PELLETS CREON (PANCRELIPASE) CAPSULE, DELAYED RELEASE [ABBVIE INC.] | 57 | |
| PANCRELIPASE PROTEASE | ACTIVE MOIETY | 3560D81V50 | CREON (PANCRELIPASE) CAPSULE, DELAYED RELEASE PELLETS CREON (PANCRELIPASE) CAPSULE, DELAYED RELEASE [ABBVIE INC.] | 57 | |
| PANCRELIPASE PROTEASE | ACTIVE MOIETY | 3560D81V50 | ZENPEP (PANCRELIPASE) CAPSULE, DELAYED RELEASE [APTALIS PHARMA US, INC.] | 17 | |
| PANCRELIPASE PROTEASE | ACTIVE INGREDIENT | 3560D81V50 | ZENPEP (PANCRELIPASE) CAPSULE, DELAYED RELEASE [APTALIS PHARMA US, INC.] | 17 | |
| PANCRELIPASE PROTEASE | ACTIVE INGREDIENT | 3560D81V50 | PANCRELIPASE CAPSULE, DELAYED RELEASE [X-GEN PHARMACEUTICALS, INC.] | 14 | |
| PANCRELIPASE PROTEASE | ACTIVE MOIETY | 3560D81V50 | PANCRELIPASE CAPSULE, DELAYED RELEASE [X-GEN PHARMACEUTICALS, INC.] | 14 | |
| PANCRELIPASE PROTEASE | ACTIVE MOIETY | 3560D81V50 | PERTZYE (PANCRELIPASE) CAPSULE, DELAYED RELEASE [DIGESTIVE CARE, INC.] | 12 | |
| PANCRELIPASE PROTEASE | ACTIVE INGREDIENT | 3560D81V50 | PERTZYE (PANCRELIPASE) CAPSULE, DELAYED RELEASE [DIGESTIVE CARE, INC.] | 12 | |
| PANCRELIPASE PROTEASE | ACTIVE INGREDIENT | 3560D81V50 | PANCREAZE (PANCRELIPASE) CAPSULE, DELAYED RELEASE [JANSSEN PHARMACEUTICALS, INC.] | 5 | |
| PANCRELIPASE PROTEASE | ACTIVE MOIETY | 3560D81V50 | PANCREAZE (PANCRELIPASE) CAPSULE, DELAYED RELEASE [JANSSEN PHARMACEUTICALS, INC.] | 5 | |
| PANCRELIPASE PROTEASE | ACTIVE INGREDIENT | 3560D81V50 | ULTRESA (PANCRELIPASE) CAPSULE, DELAYED RELEASE [APTALIS PHARMA US, INC] | 4 | |
| PANCRELIPASE PROTEASE | ACTIVE MOIETY | 3560D81V50 | ULTRESA (PANCRELIPASE) CAPSULE, DELAYED RELEASE [APTALIS PHARMA US, INC] | 4 | |
| PANCRELIPASE PROTEASE | ACTIVE INGREDIENT | 3560D81V50 | PANAKARE PLUS (PANCREATIC ENZYME) TABLET [NEOGEN CORPORATION-MERCER] | 3 | |
| PANCRELIPASE PROTEASE | ACTIVE MOIETY | 3560D81V50 | PANAKARE PLUS (PANCREATIC ENZYME) TABLET [NEOGEN CORPORATION-MERCER] | 3 | |
| PANCRELIPASE PROTEASE | ACTIVE MOIETY | 3560D81V50 | VIOKACE (PANCRELIPASE) TABLET [APTALIS PHARMA US, INC] | 3 | |
| PANCRELIPASE PROTEASE | ACTIVE INGREDIENT | 3560D81V50 | VIOKACE (PANCRELIPASE) TABLET [APTALIS PHARMA US, INC] | 3 | |
| PANCRELIPASE PROTEASE | ACTIVE INGREDIENT | 3560D81V50 | PANAKARE PLUS (PANCREATIC ENZYME ) POWDER [NEOGEN CORPORATION-MERCER] | 2 | |
| PANCRELIPASE PROTEASE | ACTIVE MOIETY | 3560D81V50 | PANAKARE PLUS (PANCREATIC ENZYME ) POWDER [NEOGEN CORPORATION-MERCER] | 2 | |
| PANCRELIPASE PROTEASE | ACTIVE INGREDIENT | 3560D81V50 | PANCRELIPASE CAPSULE, DELAYED RELEASE [KAISER FOUNDATION HOSPITALS] | 2 | |
| PANCRELIPASE PROTEASE | ACTIVE MOIETY | 3560D81V50 | PANCREAPOWDER PLUS (PANCREATIC ENZYME CONCENTRATE PLUS FAT SOLUBLE VITAMINS) POWDER [HENRY SCHEIN ANIMAL HEALTH] | 1 | |
| PANCRELIPASE PROTEASE | ACTIVE INGREDIENT | 3560D81V50 | PANCREAPOWDER PLUS (PANCREATIC ENZYME CONCENTRATE PLUS FAT SOLUBLE VITAMINS) POWDER [HENRY SCHEIN ANIMAL HEALTH] | 1 | |
| PANCRELIPASE PROTEASE | ACTIVE MOIETY | 3560D81V50 | PANCREPLUS (PANCREATIC ENZYME) TABLET [MWI/VETONE] | 1 | |
| PANCRELIPASE PROTEASE | ACTIVE INGREDIENT | 3560D81V50 | PANCREPLUS (PANCREATIC ENZYME) TABLET [MWI/VETONE] | 1 | |
| PANCRELIPASE PROTEASE | ACTIVE MOIETY | 3560D81V50 | PANCREVED (PANCREATIC ENZYME) TABLET [VEDCO, INC] | 1 | |
| PANCRELIPASE PROTEASE | ACTIVE INGREDIENT | 3560D81V50 | PANCREVED (PANCREATIC ENZYME) TABLET [VEDCO, INC] | 1 | |
| PANCRELIPASE PROTEASE | ACTIVE INGREDIENT | 3560D81V50 | PANCREZYME POWDER [VIRBAC AH, INC.] | 1 | |
| PANCRELIPASE PROTEASE | ACTIVE MOIETY | 3560D81V50 | PANCREZYME POWDER [VIRBAC AH, INC.] | 1 | |
| PANCRELIPASE PROTEASE | ACTIVE MOIETY | 3560D81V50 | PANCREZYME TABLET [VIRBAC AH, INC.] | 1 | |
| PANCRELIPASE PROTEASE | ACTIVE INGREDIENT | 3560D81V50 | PANCREZYME TABLET [VIRBAC AH, INC.] | 1 | |